Salbutamol intake and substrate oxidation during submaximal exercise

European Journal of Applied Physiology

Volumn 105, Issue 2, 2009, Pages 207-213

  Arlettaz, A ^a   Le Panse, B ^a   Portier, H ^a   Lecoq, A M ^a,b   Thomasson, R ^a   De Ceaurriz, J ^c   Collomp, Katai ^a,c  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^c Agence Francaise de Lutte contre le Dopage   (France)

Author keywords

Acute intake; Albuterol; Energy expenditure; Glucose; Hormones

Indexed keywords

CORTICOTROPIN; GLUCOSE; GROWTH HORMONE; INSULIN; LACTIC ACID; LACTOSE; PLACEBO; SALBUMOL; SALBUTAMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDURANCE; ENERGY EXPENDITURE; EXERCISE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIPID OXIDATION; MALE; MORNING DOSAGE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST;

ADRENOCORTICOTROPIC HORMONE; ALBUTEROL; BLOOD GLUCOSE; EXERCISE; GROWTH HORMONE; HUMANS; INSULIN; LACTIC ACID; MALE; OXIDATION-REDUCTION; PHYSICAL ENDURANCE; PHYSICAL EXERTION; TIME FACTORS; YOUNG ADULT;

EID: 58549101864     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-008-0891-7     Document Type: Article

References (24)

1. Al-Damluji S, Perry L, Tomlin S, Bouloux P, Grossman A, Rees LH, Besser GM (1987) Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 45:68-76
2. Arlettaz A, Portier H, Lecoq A-M, Labsy Z, De Ceaurriz J, Collomp K (2008) Effects of acute prednisolone intake on substrate utilization during submaximal exercise. Int J Sports Med 29:21-26
3. Carter SL, Rennie C, Tarnopolsky MA (2001) Substrate utilization during endurance exercise in men and women after endurance training. Am J Physiol Endocrinol Metab 280:E898-E907
4. Collomp K, Candau R, Collomp R, Carra J, Lasne F, Préfaut C, De Ceaurriz J (2000a) Effects of acute ingestion of salbutamol during submaximal exercise. Int J Sports Med 21:480-484
5. Collomp K, Candau R, Lasne F, Labsy Z, Ch Préfaut, De Ceaurriz J (2000b) Effects of short-term oral salbutamol administration on exercise endurance and metabolism. J Appl Physiol 89:430-436
6. Collomp K, Candau R, Millet G, Mucci P, Borrani F, Préfaut C, De Ceaurriz J (2002) Effects of salbutamol and caffeine ingestion on exercise metabolism and performance. Int J Sports Med 23:549-554
7. Collomp K, Le Panse B, Portier H, Lecoq AM, Jaffre C, Richard O, Benhamou L, Courteix D, De Ceaurriz J (2005) Effects of acute salbutamol intake during a Wingate test. Int J Sports Med 26:513-517
8. Giustina A, Malerba M, Bresciani E, Desenzani P, Licini M, Zaltieri G, Grassi V (1995) Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis. J Endocrinol Invest 18:847-852
9. Green HJ, Jones S, Ball-Burnett M, Farrance B, Ranney D (1995) Adaptations in muscle metabolism to prolonged voluntary exercise and training. J Appl Physiol 78:138-145
10. Hoeks J, Van Baak M, Hesselink M, Hul G, Vidal H, Saris W, Schrauwen P (2003) Effect of β1- and β2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. Am J Physiol Endocrinol Metab 285:E775-E782
11. Le Panse B, Collomp K, Portier H, Lecoq AM, Jaffre C, Beaupied H, Richard O, Benhamou L, De Ceaurriz J, Courteix D (2005) Effects of short-term salbutamol ingestion during a Wingate test. Int J Sports Med 26:518-523
12. Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K (2006) Short term salbutamol ingestion and supramaximal exercise in healthy women. Br J Sports Med 40:627-631
13. Le Panse B, Arlettaz A, Portier H, Lecoq AM, De Ceaurriz J, Collomp K (2007) Effects of acute salbutamol intake during supramaximal exercise in women. Br J Sports Med 41:430-434
14. Perronet F, Massicotte D (1991) Table of nonprotein respiratory quotient: An update. Can J Sport Sci 16:23-29
15. Rolf Smith S, Kendall M (1984) Metabolic responses to β2 stimulants. J R Coll Chest Physiol 18:190-194
16. Sahlin K (1990) Muscle glucose metabolism during exercise. Ann Med 22:85-89
17. Schiffelers S, Brouwer E, Saris W, Van Baak M (1998) Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man. Metabolism 47:1462-1467
18. Schiffelers S, Saris W, Boomsma F, Van Baak M (2001) Beta(1)- and beta(2)-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J Clin Endocrinol Metab 86:2191-2199
19. Schiffelers S, Van Harmelen V, De Grauw H, Saris W, Van Baak M (1999) Dobutamine as selective β1-adrenoceptor agonist in in vivo studies on human thermogenesis and lipid utilization. J Appl Physiol 87:977-981
20. Stisen A, Stougaard O, Langfort J, Helge J, Sahlin K, Madsen K (2006) Maximal fat oxidation rates in endurance trained and untrained women. Eur J Appl Physiol 98:497-506
21. Van Baak M, Mayer L, Kempinski R, Hartgens F (2000) Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men. Med Sci Sports Exerc 32:1300-1306
22. Van Baak M, de Hon O, Hartgens F, Kuipers H (2004) Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes. Int J Sports Med 25:533-538
23. Wager J, Fredholm B, Lunell N, Persson B (1982) Metabolic and circulatory effects of intravenous and oral salbutamol in late pregnancy in diabetic and non-diabetic women. Acta Obstet Gynecol Scand Suppl 108:41-46
24. Werle E, Strobel G, Weicker H (1990) Decrease in rat cardiac beta1- and beta2-adrenoceptors by training and endurance exercise. Life Sci 46:9-17